192 related articles for article (PubMed ID: 25454080)
1. Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites.
Maayah ZH; Elshenawy OH; Althurwi HN; Abdelhamid G; El-Kadi AO
J Pharmacol Toxicol Methods; 2015; 71():33-41. PubMed ID: 25454080
[TBL] [Abstract][Full Text] [Related]
2. Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation.
Anwar-mohamed A; Zordoky BN; Aboutabl ME; El-Kadi AO
Pharmacol Res; 2010 May; 61(5):410-8. PubMed ID: 20045729
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers.
Schlezinger JJ; Parker C; Zeldin DC; Stegeman JJ
Arch Biochem Biophys; 1998 May; 353(2):265-75. PubMed ID: 9606961
[TBL] [Abstract][Full Text] [Related]
4. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses.
Lee CA; Lawrence BP; Kerkvliet NI; Rifkind AB
Toxicol Appl Pharmacol; 1998 Nov; 153(1):1-11. PubMed ID: 9875294
[TBL] [Abstract][Full Text] [Related]
6. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces hepatic cytochrome P450-dependent arachidonic acid epoxygenation in diverse avian orders: regioisomer selectivity and immunochemical comparison of the TCDD-induced P450s to CYP1A4 and 1A5.
Gilday D; Bellward GD; Sanderson JT; Janz DM; Rifkind AB
Toxicol Appl Pharmacol; 1998 May; 150(1):106-16. PubMed ID: 9630459
[TBL] [Abstract][Full Text] [Related]
7. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol.
Althurwi HN; Maayah ZH; Elshenawy OH; El-Kadi AO
Drug Metab Dispos; 2015 Aug; 43(8):1254-66. PubMed ID: 26033621
[TBL] [Abstract][Full Text] [Related]
8. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy.
Althurwi HN; Elshenawy OH; El-Kadi AO
J Cardiovasc Pharmacol; 2014 Feb; 63(2):167-77. PubMed ID: 24157956
[TBL] [Abstract][Full Text] [Related]
10. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
11. The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Maayah ZH; Abdelhamid G; Elshenawy OH; El-Sherbeni AA; Althurwi HN; McGinn E; Dawood D; Alammari AH; El-Kadi AOS
Cardiovasc Toxicol; 2018 Jun; 18(3):268-283. PubMed ID: 29196978
[TBL] [Abstract][Full Text] [Related]
12. Identification of rabbit cytochromes P450 2C1 and 2C2 as arachidonic acid epoxygenases.
Laethem RM; Koop DR
Mol Pharmacol; 1992 Dec; 42(6):958-63. PubMed ID: 1480136
[TBL] [Abstract][Full Text] [Related]
13. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
14. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
15. Induction of CYP1A and cyp2-mediated arachidonic acid epoxygenation and suppression of 20-hydroxyeicosatetraenoic acid by imidazole derivatives including the aromatase inhibitor vorozole.
Diani-Moore S; Papachristou F; Labitzke E; Rifkind AB
Drug Metab Dispos; 2006 Aug; 34(8):1376-85. PubMed ID: 16714371
[TBL] [Abstract][Full Text] [Related]
16. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis.
Michaelis UR; Fisslthaler B; Barbosa-Sicard E; Falck JR; Fleming I; Busse R
J Cell Sci; 2005 Dec; 118(Pt 23):5489-98. PubMed ID: 16291720
[TBL] [Abstract][Full Text] [Related]
18. Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl/6 mice.
Anwar-Mohamed A; Elshenawy OH; El-Sherbeni AA; Abdelrady M; El-Kadi AO
Can J Physiol Pharmacol; 2014 Aug; 92(8):693-702. PubMed ID: 25065748
[TBL] [Abstract][Full Text] [Related]
19. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle.
Grasso E; Longo V; Coceani F; Giovanni Gervasi P
Biochim Biophys Acta; 2005 Mar; 1722(2):116-23. PubMed ID: 15716024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
